Hepatoma in the noncirrhotic liver.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 2843280)

Published in Cancer on October 01, 1988

Authors

S R Smalley1, C G Moertel, J F Hilton, L H Weiland, H S Weiand, M A Adson, L J Melton, K Batts

Author Affiliations

1: Department of Oncology, Mayo Clinic, Rochester, Minnesota.

Articles by these authors

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer (1981) 3.86

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44

High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Carcinoid tumors of the vermiform appendix. Cancer (1968) 3.07

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97

Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg (1976) 2.96

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet (1969) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med (1980) 2.72

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63

Resection of liver metastases--when is it worthwhile? World J Surg (1987) 2.59

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51

Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47

The physician's responsibility toward hopelessly ill patients. N Engl J Med (1984) 2.46

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43

Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol (1983) 2.41

Major hepatic resections for metastatic colorectal cancer. Ann Surg (1980) 2.41

Leiomyosarcoma of the small and large bowel. Cancer (1978) 2.39

Cysts of the larynx--classification. Laryngoscope (1970) 2.38

Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res (1999) 2.37

Primary hepatic malignancy: surgical management and determinants of survival. Surgery (1989) 2.35

Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA (1985) 2.35

Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol (1985) 2.26

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25

Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24

Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol (1989) 2.24

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23

Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20

Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17

Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17

Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17

Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17

Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br J Surg (1986) 2.16

Outcomes of surgery in patients 90 years of age and older. JAMA (1989) 2.15

Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15

A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13

Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12

Multiple primary malignant neoplasms: historical perspectives. Cancer (1977) 2.11

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11